Intended for healthcare professionals

Letters Bad medicine: the way we manage diabetes

European Medicines Agency must take account of cardiovascular harm associated with degludec insulin

BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f3731 (Published 11 June 2013) Cite this as: BMJ 2013;346:f3731